ArticleClinical medicine insights. Case reports2026
Hyperinflammatory Syndrome of Unknown Origin Complicated by Shock, DIC, Intracranial Hemorrhage and Spontaneous Splenic Rupture: A Case Report.
Article in Clinical medicine insights. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperinflammation syndrome is a life-threatening condition of heterogeneous etiology. Common manifestations include fever, organomegaly, leukopenia or leukocytosis and malaise. We would like to present a rare case of hyperinflammatory syndrome of unknown origin complicated by shock, severe coagulopathy, spontaneous splenic rupture, and intracranial hemorrhage. A 24-year-old man with no past medical history was admitted to intensive care unit presenting with hemodynamic instability, severe acidosis, splenomegaly, bi-cytopenia, with significantly elevated inflammatory markers. Broad spectrum microbiology, hematology and genetic tests were performed to identify a trigger. Due to presence of both sepsis and hemophagocytic lymphohistiocytosis features (HLH), sepsis-HLH overlap syndrome was suspected. Aggressive treatment (broad-spectrum antibiotics, immunomodulation therapy, therapeutic plasma exchange and renal replacement therapy) was instantly initiated. Despite that, shock and profound disseminated intravascular coagulopathy exacerbated. Unexpected splenic rupture and intracranial hemorrhage required urgent surgical intervention, along with amputation of distal foot phalanges due to severe ischemia. Treatment in the intensive care unit lasted 40 days. One year after a discharge from ICU, patient still required neurological rehabilitation and orthopedic treatment. We do hope that this case will make clinicians more aware of HLH and sepsis-HLH overlap syndrome. Further research is required to improve treatment of severe hyperinflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.